Warning: The NCBI web site requires JavaScript to function. more...
Optimised electroporation mediated DNA vaccination for treatment of prostate cancer.
Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC.
Genet Vaccines Ther. 2010 Feb 5;8(1):1.
Related citations
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.
Pavlenko M, Roos AK, Lundqvist A, Palmborg A, Miller AM, Ozenci V, Bergman B, Egevad L, Hellström M, Kiessling R, Masucci G, Wersäll P, Nilsson S, Pisa P.
Br J Cancer. 2004 Aug 16;91(4):688-94.
Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.
Mol Ther. 2009 Jun;17(6):1101-8. Epub 2009 Mar 31.
[Novel vaccines against M. tuberculosis].
Okada M.
Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
Best SR, Peng S, Juang CM, Hung CF, Hannaman D, Saunders JR, Wu TC, Pai SI.
Vaccine. 2009 Sep 4;27(40):5450-9. Epub 2009 Jul 19.
A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models.
Jiao JG, Li YN, Wang H, Liu Q, Cao JX, Bai RZ, Huang FY.
Dig Liver Dis. 2006 Aug;38(8):578-87. Epub 2006 Jun 13.
The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA.
Ohlschläger P, Spies E, Alvarez G, Quetting M, Groettrup M.
Int J Cancer. 2011 Jan 15;128(2):473-81. doi: 10.1002/ijc.25344. Epub 2010 Mar 22.
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.
Roos AK, Eriksson F, Timmons JA, Gerhardt J, Nyman U, Gudmundsdotter L, Bråve A, Wahren B, Pisa P.
PLoS One. 2009 Sep 30;4(9):e7226.
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
Saha A, Baral RN, Chatterjee SK, Mohanty K, Pal S, Foon KA, Primus FJ, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M.
Cancer Immunol Immunother. 2006 May;55(5):515-27. Epub 2005 Jul 26.
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
Slovin SF, Ragupathi G, Musselli C, Fernandez C, Diani M, Verbel D, Danishefsky S, Livingston P, Scher HI.
Cancer Immunol Immunother. 2005 Jul;54(7):694-702. Epub 2005 Feb 22.
Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses.
Grønevik E, Mathiesen I, Lømo T.
J Gene Med. 2005 Sep;7(9):1246-54.
Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation.
Kotecha MT, Afghan RK, Vasilikopoulou E, Wilson E, Marsh P, Kast WM, Davies DH, Caparros-Wanderley W.
Vaccine. 2003 Jun 2;21(19-20):2506-15.
Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J.
J Immunol. 2005 May 15;174(10):6292-8.
In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells.
Ahlén G, Söderholm J, Tjelle T, Kjeken R, Frelin L, Höglund U, Blomberg P, Fons M, Mathiesen I, Sällberg M.
J Immunol. 2007 Oct 1;179(7):4741-53.
Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
J Gene Med. 2007 Aug;9(8):715-26.
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.
Kadowaki S, Chen Z, Asanuma H, Aizawa C, Kurata T, Tamura S.
Vaccine. 2000 Jun 15;18(25):2779-88.
Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants.
Kim JJ, Yang JS, Dang K, Manson KH, Weiner DB.
Clin Cancer Res. 2001 Mar;7(3 Suppl):882s-889s.
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
Vaccine. 2009 Jun 8;27(28):3692-6. Epub 2009 May 3.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on